NYSE Arca · PBE

Invesco Biotechnology & Genome ETF (PBE)

$97.29+0.03%
Close Sep 28, 2026 · split-adjusted
Sep 28, 2026$97.29▲ 40.69% in range
Sep 29, 2025Low $69.15 · High $98.73Sep 28, 2026
What changed · written from our data
As of Sep 28, 2026

Invesco Biotechnology & Genome ETF closed at $97.29 on Sep 28, up 0.03%, 1.5% below its 52-week closing high. Volume of 12.1K shares was 0.59× its 20-day average (below normal).

Split-adjusted performance: -1.3% over one month, +28.7% over six months, +43.4% over one year.

Short interest was 12.3K shares at the Sep 15 settlement, down 46.9% from the prior report (1.0 days to cover).

Market cap$424.2M4.4M shares
Revenue · quarter——
Diluted EPS——
P/E · TTM—
Net margin—
Dividend yield0.08%$0.0187 last paid
52-week range67.85 – 98.73−1.5% from high
Volume12.1K0.59× 20-day avg
Volatility · 60d19.0%Annualised
Short % of float—1.0 days to cover
Net cash—
Next earnings—Not scheduled
Split-adjusted performance
1W +1.4%1M −1.3%3M +8.4%6M +28.7%YTD +18.4%1Y +43.4%3Y +68.3%5Y +27.7%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within industry

Not enough peers to rank

6-month momentum—
Revenue growth—
Net margin—
Value (low P/E)—
Size—

Short interest

Details →
Shares short12.3K−46.9% vs prior
Days to cover1.0Settled Sep 15
% of float—
Short vol. 10d43.8%of daily volume

Quick answers

What is PBE's market cap?
$424.16M, based on the Sep 28 close of $97.29.
Does Invesco Biotechnology & Genome ETF pay a dividend?
Yes. The latest regular dividend was $0.0187 per share (ex-date Sep 21), an annualised yield of 0.08%.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology